You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
司太立(603520.SH):子公司海神製藥停產整治
格隆匯 12-04 16:41

格隆匯12月4日丨司太立(603520.SH)公佈,2019年12月4日,公司收到控股子公司海神製藥的通知,海神製藥於近日收到台州市生態環境局出具的《責令停產整治告知書》(台環責告停字[2019]5-1006號),責令海神製藥就其前期調查發現的環境違法行為進行停產整改。截至公告披露日,海神製藥已按照相關要求暫停生產並開展整改工作。

海神製藥成立於2003年9月28日,位於浙江省化學原料藥基地臨海園區,註冊資本為人民幣壹億元,經營範圍為原料藥(碘海醇、碘帕醇、碘克沙醇)製造。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

海神製藥系公司控股子公司,公司持有海神製藥98.20%股權,目前擁有180噸/年碘海醇生產線,100噸/年碘帕醇生產線,佔公司碘造影劑原料藥整體產能的23.73%。

此次停產整治的原因系2019年9月12日台州市生態環境局在對海神製藥進行檢查時,發現海神製藥在生產物料轉運過程中產生跑冒滴漏現象,經雨水沖刷進入地表,未對區域污水進行有效處置,造成部分地表水超標。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account